Cargando…
Gut microbiota and COVID-19: An intriguing pediatric perspective
Gastrointestinal (GI) involvement has been reported in approximately 50% of patients with coronavirus disease 2019 (COVID-19), which is due to the pathogenic role of inflammation and the intestinal function of the angiotensin-converting enzyme 2 and its receptor. Accumulating adult data has pointed...
Autores principales: | Valentino, Maria Sole, Esposito, Claudia, Colosimo, Simone, Caprio, Angela Maria, Puzone, Simona, Guarino, Stefano, Marzuillo, Pierluigi, Miraglia del Giudice, Emanuele, Di Sessa, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403663/ https://www.ncbi.nlm.nih.gov/pubmed/36159525 http://dx.doi.org/10.12998/wjcc.v10.i23.8076 |
Ejemplares similares
-
COVID-19 and pediatric fatty liver disease: Is there interplay?
por: Di Sessa, Anna, et al.
Publicado: (2021) -
Omics era in type 2 diabetes: From childhood to adulthood
por: Passaro, Antonio Paride, et al.
Publicado: (2021) -
Telemedicine in the COVID-19 era: Taking care of children with obesity and diabetes mellitus
por: Umano, Giuseppina Rosaria, et al.
Publicado: (2021) -
Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
por: Di Sessa, Anna, et al.
Publicado: (2021) -
Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions
por: Lanzaro, Francesca, et al.
Publicado: (2022)